ustekinumab

Italy

Drugs containing this active substance

  • FYMSKINA

    Fymskina is used for the treatment of certain inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults and children weighing at least 40 kg).

    Form: solution for injection in pre-filled syringe

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: FORMYCON AG

  • It is used to treat certain inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults and children weighing at least 40 kg).

    Form: solution for injection in pre-filled syringe

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: ACCORD HEALTHCARE, S.L.U.

  • Otulfi is used for the treatment of certain inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults and children weighing at least 40 kg).

    Form: solution for injection in pre-filled syringe

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: FRESENIUS KABI DEUTSCHLAND GMBH

  • Pyzchiva is used for the treatment of certain inflammatory diseases, including plaque psoriasis, psoriatic arthritis, and Crohn's disease (moderate to severe).

    Form: solution for injection in pre-filled syringe

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: SAMSUNG BIOEPIS NL B.V.

  • It is used to treat several inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), Crohn's disease (moderate to severe, in adults and children weighing at least 40 kg), and ulcerative colitis (moderate to severe, in adults).

    Form: solution for injection in pre-filled syringe

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: CELLTRION HEALTHCARE HUNGARY KFT

  • Stelara is used for the treatment of several inflammatory diseases, including Crohn's disease (moderate to severe), ulcerative colitis (moderate to severe), plaque psoriasis, and psoriatic arthritis.

    Form: solution for injection

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: JANSSEN-CILAG INTERNATIONAL N.V.

  • Steqeyma is an immunosuppressant drug used for the treatment of inflammatory diseases such as plaque psoriasis, psoriatic arthritis, and Crohn's disease (moderate to severe).

    Form: solution for injection in pre-filled syringe

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: CELLTRION HEALTHCARE HUNGARY KFT

  • Usgena is used for the treatment of several inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), moderate to severe Crohn's disease (in adults), and moderate to severe ulcerative colitis (in adults).

    Form: solution for injection

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: STADA ARZNEIMITTEL AG

  • Usrenty is used for the treatment of certain inflammatory diseases: plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults).

    Form: solution for injection

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: BIOSIMILAR COLLABORATIONS IRELAND LIMITED

  • Usymro is used to treat several inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults and children weighing at least 40 kg).

    Form: solution for injection

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: GEDEON RICHTER PLC

  • Uzpruvo is used for the treatment of certain inflammatory diseases, including plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults and children weighing at least 40 kg).

    Form: solution for injection in pre-filled syringe

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: STADA ARZNEIMITTEL AG

  • It is used to treat moderate to severe Crohn's disease in adults and children weighing at least 40 kg. It is also indicated for plaque psoriasis (adults and children from 6 years of age) and psoriatic arthritis (adults).

    Form: solution for injection

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: AMGEN TECHNOLOGY (IRELAND) UC

  • It is used to treat plaque psoriasis (in adults and children from 6 years of age), psoriatic arthritis (in adults), and moderate to severe Crohn's disease (in adults).

    Form: solution for injection

    Active substance Dosage
    ustekinumab -

    ATC: L04AC05

    Manufacturer: BIOSIMILAR COLLABORATIONS IRELAND LIMITED